Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Bin Teh, M.D.

Bin S. Teh, M.D.


Bin S. Teh, M.D.

Bin S. Teh, M.D.

Full Member
The Methodist Hospital Research Institute

Vice Chair, Department of Radiation Oncology
The Methodist Hospital

Professor and Vice Chair of Radiation Oncology 
Weill Cornell Medical College of Cornell University

E-mail: bteh@houstonmethodist.org
Phone: 713-441-4800


B.M.S.   University of Queensland, Brisbane, Queensland, Australia
M.D.   University of Queensland, Brisbane, Queensland, Australia

Postdoctoral Training

Tutor, Embryology and Gross, Department of Anatomy, University of Queensland, Brisbane, Queensland, Australia
Internship, Mater Misericordiae Hospitals, Queensland, Australia
Oncology Internship, Categorical Radiation, Baylor College of Medicine, Houston, TX
Residency, Radiation Oncology, Baylor College of Medicine, Houston, TX (Chief Resident)
Fellowship, in Three-Dimensional Conformal Radiotherapy (3DCRT) and Intensity Modulation Radiation Therapy (IMRT), Baylor College of Medicine, Houston, TX



Dr. Teh is a professor and vice chair of the Department of Radiation Oncology at The Methodist Hospital and Weill Medical School of Cornell. Dr. Teh has contributed significantly to the field of radiation oncology – encompassing radiotherapy technology, radiation physics, molecular radiobiology and the translation of advances in these areas to clinical use. He has been instrumental in pioneering new technology in radiation oncology including APBI (accelerated partial breast irradiation), IMRT (intensity-modulated radiation therapy), IGRT (image-guided radiation therapy), SBRT (stereotactic body radiation therapy), SRS (stereotactic radiosurgery), brachytherapy as well as combined radiotherapy and gene therapy. Dr. Teh treated the first breast cancer patient in Houston with multi-lumen catheter (Contura) high dose rate brachytherapy for partial breast irradiation. This is a short course of five days irradiation, as compared to the conventional six weeks irradiation for breast cancer. Partial breast irradiation is a novel approach to spare more normal tissues.

Dr. Teh earned his medical degree from the University of Queensland in Queensland, Australia. He completed his Radiation Oncology residency, training and fellowship in IMRT at the Baylor College of Medicine in Houston, Texas. Dr. Teh is active in ASTRO (American Society of Therapeutic Radiology and Oncology), RSNA (Radiological Society of North America and ARS (American Radium Society). He is the principal investigator for RTOG (Radiation Therapy Oncology Group) at The Methodist Hospital. Dr. Teh has published more than 100 peer-reviewed articles on topics such as IMRT for breast cancer, editorials, 15 book chapters and a textbook on PET-CT in radiotherapy. He plays an important role in breast cancer patient care, clinical research and the education of residents and students.

Description of Research

Dr. Teh’s research focuses on the treatment of genito-urinary malignancies and unlocking the myth of radio-resistance in cancers especially renal cell carcinoma. Other research interests include Intensity modulated radiation therapy (IMRT) for prostate cancer, head and neck cancer, central nervous system tumor, pediatric cancer and breast cancer, stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), stereotactic radiation therapy (SRT) and image-guided radiation therapy (IGRT), brachytherapy for prostate cancer, breast cancer and endobronchial tumors, SRS and SBRT for primary and metastatic renal cell carcinoma as well as hepatocellular carcinoma, the role of combined radiotherapy and gene therapy for cancers including prostate cancer, renal cell carcinoma, bladder cancer, pancreatic cancer, glioblastoma multiforme, cervical cancer and head and neck cancer, combining targeted therapy (AKT-inhibitor, mTOR inhibitor, tyrosine kinase inhibitor) with radiotherapy for cancer treatment, and combining oncolytic virus with radiotherapy in overcoming radio-resistant tumors in oncology.

Major Areas of Research

Cancer stem cells and radio-resistance, Prostate Movement study, Post-prostatectomy IMRT, Gene expression profiling in cancer and Proteomics in oncology.

Recent Publications

Paulino AC, Mai WY, Chintagumpala M, Taher A, Teh BS. Radiation induced malignant glioma: is there a role for reirradiation? Int J Rad Oncol Biol Phys 2008 Feb 8.

Jhaveri P, Teh BS, Bloch C, Amato R, Butler EB, Paulino AC. Stereotactic body radiotherapy in the management of painful bone metastases. Oncology 2008; 22(7):782-789.

Teh BS, Ortiz P, Paulino AC, Bloch C, Grant WH III, Butler EB. Pioneering innovative radiation oncology technology in clinics. Biomed Imaging Interv J 2007;(3):e57.

Curtis AE, Okcu MF, Chintagumpala M, Teh BS, Paulino AC. Local control after intensity-modulated radiotherapy for head and neck rhabdomyosarcoma. Int J Rad Oncolo Biol Phys (in press).

Paulino AC, Nguyen TX, Mai WY, Teh BS, Wen BC. Dose response and local control using radiotherapy in non-metastatic Ewing’s sarcoma. Pediatric Blood and Cancer (in press).

Cohen KH, Teh BS, Paulino AC, Butler EB. Ureteral stenosis following post-prostatectomy intensity modulated radiotherapy (IMRT). Am J Clin Oncol (in press).

Fei H, Tai-Xiang L, Chong Z, Li-Xia L, Shao-Min H, Xiao-Wu D, Ying H, Cheng-Guang L, Wei-Yuan M, Teh BS. Outcomes and prognostic factors of reirradiation for locally recurrent nasopharyngeal carcinoma using intensity modulated radiotherapy (IMRT): the experience of sun yat-sen university. Int J Rad Oncol Biol Phys (accepted). Paulino AC and Teh BS.

PET-CT in Radiotherapy Treatment Planning. (textbook) Elsevier Press, 2008.